| 000 | 01389 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517204130.0 | ||
| 264 | 0 | _c20190109 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1873-2968 | ||
| 024 | 7 |
_a10.1016/j.bcp.2018.03.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohamed, Yasmin S | |
| 245 | 0 | 0 |
_aRole of nitric oxide and KATP channel in the protective effect mediated by nicorandil in bile duct ligation-induced liver fibrosis in rats. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _c05 2018 |
||
| 300 |
_a135-142 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aCholestasis _xcomplications |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aKATP Channels _xmetabolism |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNicorandil _xadministration & dosage |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aProtective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aAhmed, Lamiaa A | |
| 700 | 1 | _aSalem, Hesham A | |
| 700 | 1 | _aAgha, Azza M | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 151 _gp. 135-142 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bcp.2018.03.003 _zAvailable from publisher's website |
| 999 |
_c28162890 _d28162890 |
||